FDA Panel Rejects Avastin for Breast Cancer:
But it did approve Ixempra
FDA
Expert Summary
While it rejected Avastin for breast cancer treatment, the FDA recently approved Ixempra for treatment of advanced breast cancer. Find out more about Ixempra and how it works here.
Deanna Durica
Expert Scorecard
Overall Expert Score
Community Reviews
Overall Community Rating:
(0 reviews)
Add your rating:
click to select